Purchase Order 75N95024P00555
Award Date
9/4/24
Potential Completion Date
12/31/24
Potential Value
$25K
Federal Agency
National Institute on Drug Abuse
Awardee
Biocytogen Boston Corp
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $156,200 firm fixed price purchase order to Biocytogen Boston Corp. to provide services for the transgenic development of HIV-related rats. Per the original solicitation, the contractor will design plasmid and targeting vector construction, complete microinjections and screening in multiple rat lines, and conduct breeding and genotyping to deliver the developed rat lines within...
<p>Biocytogen Boston Corporation was awarded a firm fixed price purchase order valued at thirteen thousand one hundred dollars by the National Institutes of Health's National Institute on Drug Abuse. The contract is for the delivery of FOS-T2A-ICREERT2 knockin Sprague Dawley rats to the agency's facilities in Baltimore, Maryland. No set-aside designation was applied to this procurement. Work under the contract is to be completed by February 21, 2025.</p>
This federal contract award to Cyagen Biomodels LLC, a biotechnology company based in Santa Clara, California, is for the replacement of a previous purchase order from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $30,915.00 firm-fixed-price purchase order does not have a set-aside designation. Cyagen Biomodels LLC specializes in providing custom genetic model services to support biomedical research, including the creation of...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This purchase order contract was awarded by the National Institutes of Health's National Institute on Drug Abuse to Transnetyx, Inc., doing business as Harmonyx Diagnostics, for genotyping services for transgenic rats and mice in support of an HIV project. The solicitation sought proposals to provide such services for a one-year base period of performance from August 8, 2023 through August 7, 2024 at a value of $30,000. The contractor will genotype research subjects, provide additional...
The National Institute on Drug Abuse (NIDA) awarded a $696,897.52 cost-plus-fixed-fee delivery order to Charles River Laboratories, Inc. for the development and maintenance of a multigenotypic caloric restricted rodent colony. This task order, which has an ultimate completion date of April 14, 2022, supports NIDA's research initiatives in aging and caloric restriction. The award is not set aside for any specific business type. Charles River Laboratories is a global contract research organization...
This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...
This is a $15,000 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Transnetyx, Inc., a for-profit organization specializing in genetic testing and analysis services. The contract is for genotyping services to identify the genotypes of rodents bred by the NIDA (National Institute on Drug Abuse). The award has no set-aside designation, indicating...
The federal contract award is for the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to procure supplies from Med Associates, Inc., a for-profit, woman-owned manufacturer of scientific equipment and software. The $16,287.50 firm fixed price purchase order is to provide the laboratory members of NIDA researcher Leandro Vendruscolo with items needed to perform experiments involving alcohol and opioids in mice and rats. The contract does not have a set-aside...
This federal contract award to Transnetyx, Inc., a for-profit organization, is for the provision of automated genotyping services to support biomedical research across various federal agencies. The $24,000 firm fixed-price purchase order is being issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS). Transnetyx has extensive experience supporting research initiatives at the National Institutes of Health (NIH), including the...